Mergers & Acquisitions

  • November 10, 2025

    FTC Dem Tells Justices Case Law Supports Her Reinstatement

    Fired Federal Trade Commissioner Rebecca Slaughter has argued that in taking up her appeal over President Donald Trump's decision to remove her before her term was up, the U.S. Supreme Court is really mulling whether it has "gotten it wrong for the last 90 years."

  • November 10, 2025

    Apollo Sports Capital Takes Majority Stake In Atlético Madrid

    Apollo Sports Capital, guided by Allen Overy Shearman Sterling, said Monday it will acquire a majority stake in Spanish soccer club Atlético de Madrid, but did not disclose financial details.

  • November 10, 2025

    Medtech Co-Founder Tells Chancery Father-Son Cut Him Out

    A co-founder of a medtech company has sued in the Delaware Chancery Court alleging the two other co-founders, who are father and son, of engineering a covert squeeze-out aimed at stripping him of his 30% ownership stake just as the company approached a potentially lucrative fundraiser.

  • November 10, 2025

    ​​​​​​​Ex-CFO Says Steel Co. Broke Severance Deal After Sale

    The former chief financial officer of a Pittsburgh-area steel company told a Pennsylvania state court he was promised severance pay when he was terminated as part of the company's sale, but has yet to get any of the $112,500 he signed up for.

  • November 10, 2025

    FTC Risks Help Push Metsera Back To Pfizer

    Novo Nordisk AS' aspirations to pry Metsera away from Pfizer Inc. collapsed over the weekend under the pressure of a revised Pfizer offer, twin court challenges and "a call from the U.S. Federal Trade Commission."

  • November 10, 2025

    Kirkland Guides KKR'S $2.2B Novaria Sale To Arcline

    Private equity giant KKR announced Monday plans to sell Texas-based aerospace component-supplier Novaria Group to Arcline Investment Management in an all-cash transaction valued at $2.2 billion, guided by Kirkland & Ellis LLP for KKR and Novaria, and Ropes & Gray LLP and Paul Hastings LLP for Tennessee-based Arcline.

  • November 10, 2025

    Sunnova Ch. 11 Wind-Down Approved Over Release Objection

    The Chapter 11 liquidation plan of solar panel company Sunnova Energy International received bankruptcy court approval Monday in Texas after a judge overruled objections to third-party releases raised by the U.S. Trustee's Office.

  • November 10, 2025

    PE Firm Investindustrial Inks $2.9B Deal For TreeHouse Foods

    Private equity firm Investindustrial has struck a deal to acquire food manufacturer TreeHouse Foods Inc. for $2.9 billion in an all-cash transaction that will take the company private, the two companies announced Monday.

  • November 10, 2025

    Chancery Drops Claims In Murder-Linked Bio Co. Merger Fight

    The Delaware Chancery Court dismissed a biotech company's claims against the husband and investment vehicle of convicted fraudster Serhat Gumrukcu, whose murder-for-hire plot allegedly helped conceal past misconduct ahead of a 2018 merger.

  • November 10, 2025

    Catching Up With Delaware's Chancery Court

    Delaware's top court issued a flurry of rulings last week and heard arguments on recently passed legislation that expanded liability shields for some corporate acts while the Court of Chancery passed on another round of arguments over control of Caribbean broadcaster Caribevision.

  • November 10, 2025

    Clifford Chance Steers Permira's £2.3B Bid For JTC

    Fund administrator JTC PLC said Monday that it has backed a £2.3 billion ($3 billion) cash offer from British private equity shop Permira, as it becomes the latest London-listed company to be taken private.

  • November 07, 2025

    Delaware Fee Inflation Worries Overblown, Study Says

    A newly published report by two Stanford University researchers asserts that high-dollar attorney fee awards in Delaware courts make up "a very small minority of cases" and are "no basis for concern," throwing cold water on growing worries about so-called fee inflation in the First State.

  • November 07, 2025

    Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech

    What may be a first-of-its-kind lawsuit is playing out as Pfizer Inc. turns to antitrust law to keep Novo Nordisk from usurping its bid for Metsera.

  • November 07, 2025

    9th Circ. Pushed To Revive Suit Over $3.8B Failed Tech Merger

    A California federal judge erred in finding that investors in semiconductor company MaxLinear Inc. had no standing to sue it over what they say were misrepresentations about a $3.8 billion merger plan with chipmaker Silicon Motion Technology Corp., they told the Ninth Circuit in a bid to revive their suit.

  • November 07, 2025

    Javice Tells Chancery JPMorgan Is Stalling Appeal Fees

    Charlie Javice, the convicted founder of college financial aid startup Frank, has told a Delaware judge that JPMorgan Chase & Co. is effectively trying to cut off her ability to appeal her criminal conviction by refusing to advance the vast majority of her ongoing legal fees.

  • November 07, 2025

    3 Firms Guide Dubai Hookah Maker's $1.75B SPAC Merger

    Three law firms are guiding Dubai hookah brand owner AIR Ltd. on its agreement to go public in the U.S. through a $1.75 billion deal with blank-check firm Cantor Equity Partners III, the companies said on Friday. 

  • November 07, 2025

    Beauty Co. Says Ex-Exec's $40M Claim 'Implausible'

    The former president of a Connecticut beauty brand that L'Oréal bought for around $1 billion has made an "implausible" claim that she is owed $40 million from the sale based on an alleged verbal contract, the company said in opposing her application for a prejudgment remedy.

  • November 07, 2025

    Trump Media Q3 Loss Widens On Rising Legal Costs

    Truth Social operator Trump Media & Technology Group Corp. on Friday reported larger third-quarter losses than in the year prior due to growing legal expenses related to a special purpose acquisition company merger that took President Donald Trump's media company public last year.

  • November 07, 2025

    Taxation With Representation: Kirkland, Cravath, Paul Weiss

    In this week's Taxation With Representation, consumer products giant Kimberly-Clark acquires Tylenol maker Kenvue, shale producers SM Energy and Civitas Resources announce a merger, and power management company Eaton buys Boyd Corp.'s thermal business.

  • November 07, 2025

    Papa John's CEO Addresses 'M&A Rumors' In Q3 Call

    Days after private equity giant Apollo was said to have pulled a roughly $2.1 billion offer to purchase Papa John's, CEO Todd Penegor said Friday that the pizza chain would "fully consider" future strategic alternatives.

  • November 07, 2025

    Laborie Buys Postpartum Bleeding Device For Up To $465M

    Medical technology company Laborie Medical Technologies, advised by Simpson Thacher & Bartlett LLP and Cooley LLP, unveiled plans Friday to acquire a postpartum uterine bleeding device from New Jersey-based healthcare company Organon for up to $465 million.

  • November 07, 2025

    Solar Co. Pine Gate Hits Ch. 11 With $1B+ Debt, Sale Plan

    Solar energy developer Pine Gate Renewables has filed for Chapter 11 protection in a Texas bankruptcy court with more than $1 billion in debt and a plan to sell its business during the case.

  • November 07, 2025

    Wheaton Precious Metals To Buy US Gold Project For $670M

    Canada-based Wheaton Precious Metals Corp. said Friday that it will add a U.S. gold mine from Waterton Gold LP to its portfolio in a $670 million cash deal.

  • November 07, 2025

    UK Open To Fixes In Greencore's £1.2B Bakkavor Deal

    The Competition and Markets Authority said Friday that it is likely to accept proposals by Greencore to sell its manufacturing plant for chilled sauces to get its £1.2 billion ($1.6 billion) deal for rival Bakkavor over the line.

  • November 06, 2025

    CareFirst Urges Ban On J&J Character Talk At Stelara Trial

    Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.

Expert Analysis

  • Opinion

    DOJ's HPE-Juniper Settlement Will Help US Compete

    Author Photo

    The U.S. Department of Justice settlement with Hewlett Packard Enterprise clears the purchase of Juniper Networks in a deal that positions the U.S. as a leader in secure, scalable networking and critical digital infrastructure by requiring the divestiture of a WiFi network business geared toward small firms, says John Shu at Taipei Medical University.

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.